ZA202301377B - Pharmaceutical composition of intra-articular corticosteroid for pain control - Google Patents
Pharmaceutical composition of intra-articular corticosteroid for pain controlInfo
- Publication number
- ZA202301377B ZA202301377B ZA2023/01377A ZA202301377A ZA202301377B ZA 202301377 B ZA202301377 B ZA 202301377B ZA 2023/01377 A ZA2023/01377 A ZA 2023/01377A ZA 202301377 A ZA202301377 A ZA 202301377A ZA 202301377 B ZA202301377 B ZA 202301377B
- Authority
- ZA
- South Africa
- Prior art keywords
- intra
- pharmaceutical composition
- articular corticosteroid
- pain control
- corticosteroid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063061395P | 2020-08-05 | 2020-08-05 | |
| PCT/US2021/044619 WO2022031898A1 (en) | 2020-08-05 | 2021-08-05 | Pharmaceutical composition of intra-articular corticosteroid for pain control |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA202301377B true ZA202301377B (en) | 2026-05-27 |
Family
ID=77519828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2023/01377A ZA202301377B (en) | 2020-08-05 | 2023-02-02 | Pharmaceutical composition of intra-articular corticosteroid for pain control |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US12514820B2 (enExample) |
| EP (1) | EP4192426A1 (enExample) |
| JP (1) | JP2023537474A (enExample) |
| KR (1) | KR20230048066A (enExample) |
| CN (1) | CN116348093A (enExample) |
| AU (1) | AU2021320774A1 (enExample) |
| BR (1) | BR112023001926A2 (enExample) |
| CA (1) | CA3187955A1 (enExample) |
| CL (1) | CL2023000315A1 (enExample) |
| IL (1) | IL300354A (enExample) |
| MX (1) | MX2023001410A (enExample) |
| TW (1) | TW202220668A (enExample) |
| WO (1) | WO2022031898A1 (enExample) |
| ZA (1) | ZA202301377B (enExample) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8956600B2 (en) * | 2009-08-10 | 2015-02-17 | Taiwan Liposome Co. Ltd. | Ophthalmic drug delivery system containing phospholipid and cholesterol |
| BR112015000174A2 (pt) * | 2012-07-05 | 2017-06-27 | Taiwan Liposome Co Ltd | método para o tratamento da artrite |
| EP4389218A3 (en) * | 2017-03-14 | 2024-10-16 | Seikagaku Corporation | Composition for treating joint disease and kit containing same |
| EP3820479B1 (en) * | 2018-07-09 | 2026-03-11 | Taiwan Liposome Co., Ltd. | Methods to reduce complications of intra-articular steroid |
| IL281513B1 (en) | 2018-09-16 | 2026-07-01 | Tlc Biopharmaceuticals Inc | Preparations for the treatment of joint pain |
-
2021
- 2021-08-05 JP JP2023507244A patent/JP2023537474A/ja active Pending
- 2021-08-05 CN CN202180057600.XA patent/CN116348093A/zh active Pending
- 2021-08-05 BR BR112023001926A patent/BR112023001926A2/pt unknown
- 2021-08-05 KR KR1020237006338A patent/KR20230048066A/ko active Pending
- 2021-08-05 AU AU2021320774A patent/AU2021320774A1/en active Pending
- 2021-08-05 IL IL300354A patent/IL300354A/en unknown
- 2021-08-05 TW TW110128943A patent/TW202220668A/zh unknown
- 2021-08-05 WO PCT/US2021/044619 patent/WO2022031898A1/en not_active Ceased
- 2021-08-05 CA CA3187955A patent/CA3187955A1/en active Pending
- 2021-08-05 US US18/040,454 patent/US12514820B2/en active Active
- 2021-08-05 MX MX2023001410A patent/MX2023001410A/es unknown
- 2021-08-05 EP EP21762258.8A patent/EP4192426A1/en active Pending
-
2023
- 2023-02-01 CL CL2023000315A patent/CL2023000315A1/es unknown
- 2023-02-02 ZA ZA2023/01377A patent/ZA202301377B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112023001926A2 (pt) | 2023-03-07 |
| AU2021320774A1 (en) | 2023-03-09 |
| EP4192426A1 (en) | 2023-06-14 |
| MX2023001410A (es) | 2023-03-06 |
| US12514820B2 (en) | 2026-01-06 |
| CA3187955A1 (en) | 2022-02-10 |
| TW202220668A (zh) | 2022-06-01 |
| CL2023000315A1 (es) | 2023-09-22 |
| KR20230048066A (ko) | 2023-04-10 |
| CN116348093A (zh) | 2023-06-27 |
| US20230285293A1 (en) | 2023-09-14 |
| JP2023537474A (ja) | 2023-09-01 |
| IL300354A (en) | 2023-04-01 |
| WO2022031898A1 (en) | 2022-02-10 |